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Abstract
In childhood, chest pain occurring at exer-
cise is a common complaint. A cardiac etiology
for it is exceptionally found, explaining that
most children do not undergo systematic cardi-
ological investigation. However, chest pain at
exercise may manifest as the unique symptom
of a viral myocarditis. Recognizing this form of
myocardial injury, however, might help to avoid
clinical deterioration by providing adequate
care. In this paper, we report on two children
presenting with the unique clinical symptom
of chest pain related to physical activity and in
whom laboratory and cardiac investigations
suggested transient myocardial damage relat-
ed to myocarditis.  
Introduction
Chest pain is a common complaint in chil-
dren and is most frequently benign. In about
2% of the cases however, it has a cardiac origin
such as a valvular- or a coronary anomaly, a
pericarditis or a myocarditis.1
Myocarditis is an inflammatory disease of
the myocardium mostly due to viral infection.
Clinical manifestations of viral myocarditis in
children vary from isolated chest pain to
severe cardiac failure due to dilated cardiomy-
opathy, a severe condition that might require
invasive cardio-pulmonary support including
extracorporeal assistance and cardiac trans-
plantation or sudden death.2,3
We report on 2 otherwise healthy children
who consulted at an interval of 2 weeks in our
department because of acute chest pain occur-
ring at exercise and in whom transient
myocardial cell damage was assessed. The
diagnosis of pauci-symptomatic viral
myocarditis was suggested.
Case Reports
Case #1
A 10-year old boy without any relevant famil-
ial or personal medical history was admitted in
the emergency department in early spring
because of a first episode of retrosternal chest
pain irradiating in the left shoulder during a
football match. Chest pain ceased after he had
interrupted exercise. There was no recent his-
tory of infection.
Clinical examination was normal. Blood
pressure was 105/53 mmHg and heart rate
70/minute.
Electrocardiogram (ECG) at admission
revealed repolarization abnormalities with ST-
segment elevation in V3. 
Laboratory examinations showed ultrasen-
sitive troponin T serum concentration of 282
ng/L (normal: <14 ng/L). Leukocyte count
(8170/ mm³) and concentration of C-reactive
protein (<0.1 mL/L) were in normal range.
Four hours later, ECG showed ST-segment
elevation in V2 and V3 (Figure 1). Troponin T
concentration increased up to 660 ng/L. 
Echocardiography was normal, in particular,
the origin and course of the coronary arteries.
There was no pericardial effusion.
During his hospital stay, the patient was sta-
ble at rest. There were no cardiac dysrhyth-
mias at continuous cardiac monitoring at any
time. ECG (Figure 1) and troponin T levels nor-
malized in the next 48 h. 
Cardiac resonance magnetic imaging
(CMR) performed at day 3 confirmed the
absence of cardiac anomaly but demonstrated
a small pericardial effusion anterior to the
right ventricle (Figure 2). There were no signs
of myocardial inflammation or ischemia.
Coronarography was performed at day 4 that
permitted to definitively exclude coronary
anomaly and coronary compression by myocar-
dial bridge.
Serum titer of antibodies against coxsackie
and echovirus rose from 32 at the time of
admission to 128 at control examination 4
weeks later, revealing recent viral infection.
Serum titers of antibodies against adenovirus,
influenza A and B, parainfluenza 1, 2, 3, par-
vovirus B19, Epstein Barr virus and
cytomegalovirus were negative.
The patient was discharged without any
treatment but the recommendation to avoid
physical activity for 4 weeks until the control
examination. At that time, he was free from
any complaint. Clinical examination, echocar-
diography as well as ECG at rest and at exer-
cise, and troponin T levels after exercise were
normal. 
The patient was allowed to go back to his
normal activity including football training. At
1-year follow-up, ECG at rest and at exercise
and echocardiography were normal.
Case #2
A 7-year old boy was examined in the outpa-
tient clinic in early spring for transient ret-
rosternal chest pain that occurred a couple of
days before during sport and recurred the day
of examination while the patient was at rest.
His personal history was uneventful. There
was no recent history of infection.
Clinical examination was normal. Blood
pressure and heart rate were 102/58 mmHg
and 75/min, respectively.
ECG showed first-degree atrio-ventricular
block and ST-segment elevation in DII, DIII
and aVF (Figure 3A). 
Echocardiography including the verification
of the origin and course of the coronary arter-
ies was normal. There was no pericardial effu-
sion.
Laboratory examinations showed elevated
ultrasensitive troponin T concentrations: 147
ng/L (normal: <0.14 ng/L). Leukocytes count
(11,600/mm3) and C-reactive protein (<0.2
mg/L) were in normal range.
At CMR performed at day 3, structural or
functional myocardial- and coronary artery
anomalies were excluded. For that reason,
coronarography was not performed. Serum
titers of antibodies against adenovirus, cox-
sackies and echovirus, parvovirus B19, Epstein
Barr virus, Influenza A and B virus, parain-
fluenza 1, 2 and 3 virus, acquired immunodefi-
ciency syndrome virus, chlamydia and
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mycoplasma were all negative.
The patient was observed for 48 h until repo-
larization anomalies disappeared at ECG
(Figure 3B) and troponin-T values returned to
normal. He was discharged with the recom-
mendation to avoid physical activity for 4
weeks until control examination. ECG at rest
and at exercise, and troponin T values after
exercise on that occasion were normal. Thus,
the boy returned to his normal activity. At 1-
year follow-up, ECG at rest and at exercise and
echocardiography were normal.
Discussion
We report the case of 2 children who con-
sulted for retrosternal chest pain occurring at
physical exercise. They were previously in
good general condition allowing them to par-
ticipate to regular intensive sport training.
Both had repolarization anomalies at rest ECG
and significantly elevated troponin T concen-
trations without any biological sign of inflam-
mation.  ECG anomalies and troponin T levels
normalized in the first 2 days after admission.
Repolarization anomalies at ECG and tro-
ponin T elevation are the hallmark for myocar-
dial cell damage whatever the cause is.4 Acute
myocardial cell damage in children with so far
uneventful medical history is exceptional.5 It
might be due to congenital or acquired coro-
nary anomalies, i.e., an anomalous origin of a
coronary artery such as the anomalous origin
of the left coronary artery from the pulmonary
artery (ALCAPA),6 sequels of a Kawasaki dis-
ease,7 or inflammatory lesions to the myocardi-
um.3 These conditions might all be revealed by
chest pain at exercise. 
An anomalous origin of a coronary artery
such as ALCAPA manifests more frequently in
infants by signs of congestive heart failure
and/or myocardial infarction.6 Vascular, in par-
ticular coronary sequels of Kawasaki disease
might remain unrecognized in young children.
Indeed, Kawasaki disease is a challenging
diagnosis and not all patients affected by the
disease undergo echocardiography.
Furthermore, late coronary sequels may occur.7
Functional coronary stenosis secondary to
muscular bridges in patients with myocardial
hypertrophy or to a compression of a coronary
artery between aorta and pulmonary arterial
trunk may manifest by inaugural myocardial
ischemia.8 Selective coronarography was per-
formed in the first patient to exclude with the
last certitude such a coronary anomaly. 
Troponin T is the subunit of the troponin
complex that shows the highest sensibility and
specificity with regard to myocardial cell dam-
age.5,9 Its serum levels rise in the first 4 days
after injury and stay elevated for 6-14 days,9
correlating with the extend of injury.4
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Figure 1. Electrocardiogram of patient 1 registered at admission. ST segment is elevated
in lead V3. 25 mm/s; 10 mm/mV.
Figure 2. Cardiac magnetic resonance imaging performed in patient 1 showing normal
finding but a small pericardial effusion in front of the right ventricle (arrows).
Figure 3. Electrocardiogram registered at admission in patient 2, showing ST-elevation in
leads II, III and avF (A) and 48 h later (B) showing normal findings. First-degree auricu-
lo-ventricular block is physiologic. 50 mm/s; 10 mm/mV.
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In the case of a viral myocarditis, troponin T
is early released into the blood circulation,
before biological signs of inflammation, if any,
appear.5 This makes troponin T determination
an essential diagnostic tool in all cases of sus-
pected myocardial injury although elevated lev-
els are not specific of the cause of myocardial
cell damage.10
In both patients reported here, echocardiog-
raphy showed normal parameters of systolic
function and was therefore not contributive for
the diagnosis of myocarditis. Echocardio -
graphy remains, however, central for the diag-
nosis of all conditions where myocardial injury
is suspected, allowing the exclusion of most of
its causes.11 Nevertheless, if present, abnormal
contractility patterns are non-specific for the
cause of myocardial injury and require to be
investigated by other means.
In this respect, CMR is superior to echocar-
diography for the diagnosis of myocarditis.2,11,12
It allows evaluating different markers of tissue
injury: edema, hyperemia, necrosis and fibro-
sis.13,14 Myocardial edema is visualized in T2-
weighted sequence. Hyper-perfusion and capil-
lary leakage are shown in T1-weighted
sequence and by early gadolinium enhance-
ment while necrosis and fibrosis are shown as
late enhancement due to the penetration of
gadolinium into the intracellular space of dam-
aged cardiomyocytes. Furthermore, sub-epicar-
dial- and intra-myocardial late enhancement
suggests myocardial fibrosis related to
myocarditis while sub-endocardial late
enhancement suggests ischemic injury.12 CMR
is therefore a useful tool in discriminating 2
different causes of myocardial damage with
similar clinical manifestations. In our
patients, CMR was normal except for a small
pericardial effusion in the first one, suggest-
ing that in both cases the degree of myocardial
injury was not sufficient to allow its detection
by CMR.2
While myocardial biopsy remains the gold
standard for the definitive diagnosis of
myocarditis, its routine use in children is lim-
ited by its invasiveness and its related compli-
cations such as myocardial perforation, peri-
cardial tamponade, dysrhythmias and death.14
Furthermore, the histological interpretation is
conditioned by the biopsy size and the patchy
characteristics of myocardial lesions. In fact,
the indication of myocardial biopsy is limited
to fulminant cases or those with severe
arrhythmias.15
For these reasons, the presence in the
serum of specific antibodies directed against
the virus involved in the pathophysiology of
myocarditis is commonly investigated in chil-
dren. It must however be pointed out that in
the majority of cases, the pathogen responsible
for proven myocarditis cannot be identified by
serum titers. Indeed, in a recent study, the
virus identified by the presence of its genome
in myocardial biopsies could not be identified
by serological titers except in 4% of the
patients.16 In accordance to that, viral serum
titers were negative in our second patient. The
combination of transient ECG anomalies and
troponin T elevation as a marker for myocar-
dial cell injury in both patients, and coxsackie
and echovirus serum titer increase in the 1st
one, let us conclude to a pauci-symptomatic
viral myocarditis in both cases. This form of
viral myocarditis is challenging to diagnose
but important due to the fact its long-term out-
come is not known.17
The degree of severity of clinical manifesta-
tions of viral myocarditis depends on the
pathophysiological mechanisms and the virus
involved. Coxsackie B, echovirus, adenovirus,
parvovirus B19 and human herpes virus 6 are
the most commonly identified virus with a ten-
dency of increasing incidence of non
enteroviruses and decreasing incidence of
enteroviruses in the last 2 decades.2,11,17 Upon
myocardial infection, the disease evolves clas-
sically in 3 phases with some variability
explaining the large spectrum of clinical man-
ifestations.
In the acute viral phase, virus injures
myocardial cells leading to cell lysis and activa-
tion of the innate immunity. In most patients,
viruses will be eliminated at that stage and the
inflammatory response will be regulated and
shortly terminated without any sequel of car-
diomyocyte injury. This phase is often asymp-
tomatic. The subacute phase results from the
inefficacity to eradicate the virus. It is associ-
ated with the activation of the acquired immu-
nity. In most cases, the inflammatory reaction
diminishes while viruses are eliminated and
myocardial function recovers with myocardial
tissue repair. However, experimental murine
models showed that despite the absence of
viral genome, autoimmune processes take
place that are characterized by molecular mim-
icry allowing antibodies to be directed against
myosine or b-adrenergic receptors.
Finally, the myopathy phase is characterized
by myocardial remodeling as a result of inflam-
mation, cell death and fibrosis that leads to
dilated cardiomyopathy.17
Viruses such as parvovirus B19 and
cytomegalovirus have the potential to injure
not only cardiac myocytes but also endothelial
cells of the coronary microcirculation,18 lead-
ing to endothelial dysfunction and coronary
vasoconstriction.  This explains chest pain
patients with viral myocarditis may complain
about and the anomalies observed at ECG that
might be interpreted as signs of myocardial
infarction.17 Our patients had as unique symp-
tom chest pain that was elicited by physical
activity, indicating inadequate coronary blood
supply. Besides increased coronary demand,
physical activity in patients with viral
myocarditis could also contribute to higher
mortality by modifying the balance between
type-1 and type-2 T lymphocytes. Indeed,
severe exercise has been related to decreased
type 1 T-cell cytokine production, thus impair-
ing protection against viral infections.19 This
could be the explanation for the increased viral
replication and mortality related to severe
exercise observed four decades ago in mice
with coxsackie myocarditis.20 For these rea-
sons, physical activity must be avoided in
acute myocarditis.2 Up to now, there are no
recommendations available for the follow-up
and the duration of sport abstinence in chil-
dren with pauci-symptomatic viral myocarditis.
In the cases reported here, we arbitrarily rec-
ommended a period of sport abstinence of 4
weeks until control examination was per-
formed that confirmed fully normalization of
rest- and stress-ECG.
Conclusions
Clinical presentation of viral myocarditis in
children varies depending on the degree of
myocardial and endothelial injury. Chest pain
at physical exercise can be the unique mani-
festation of this potentially severe myocardial
disease. In order not to miss pauci-sympto-
matic forms that require adequate advice and
follow-up control, cardiac exploration with at
least ECG should be performed in all cases of
chest pain occurring at physical exercise in
children.
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